MetaADEDB 2.0 @ LMMD
candesartan cilexetil
(GHOSNRCGJFBJIB-UHFFFAOYSA-N)
Structure
SMILES
CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)OC(OC(=O)OC1CCCCC1)C
Type(s)
Approved
Molecular Formula:
C33H34N6O6
Molecular Weight:
610.660
Log P:
6.3191
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
1
TPSA:
143.34
CAS Number(s):
145040-37-5
Synonym(s)
1.
candesartan cilexetil
2.
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
3.
Amias
4.
Atacand
5.
Blopress
6.
Kenzen
7.
Parapres
8.
TCV 116
9.
TCV-116
External Link(s)
MeSHC077793
PubChem Compound2540
BindingDB50318907
ChEBI3348
CHEMBLCHEMBL1014
DrugBankDB00796
DrugCentral475
IUPHAR/BPS Guide to PHARMACOLOGY8352
KEGGcpd:C07709
dr:D00626
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 112
Canada Vigilance: 52
Canada Vigilance
US FAERS
2MalaiseFAERS: 77
Canada Vigilance: 8
Canada Vigilance
US FAERS
3Drug dose omissionFAERS: 74US FAERS
4Cerebrovascular accidentFAERS: 55
Canada Vigilance: 1
Canada Vigilance
US FAERS
5DizzinessFAERS: 54
Canada Vigilance: 23
Canada Vigilance
OFFSIDES
US FAERS
6HeadacheFAERS: 39
Canada Vigilance: 25
Canada Vigilance
US FAERS
7FatigueFAERS: 34
Canada Vigilance: 10
Canada Vigilance
OFFSIDES
US FAERS
8HypotensionFAERS: 27US FAERS
9Diabetes MellitusFAERS: 25US FAERS
10Blood pressure inadequately controlledFAERS: 22
Canada Vigilance: 19
Canada Vigilance
OFFSIDES
US FAERS
11Adverse eventFAERS: 20US FAERS
12Drug exposure during pregnancyFAERS: 20US FAERS
13NauseaFAERS: 19
Canada Vigilance: 30
Canada Vigilance
US FAERS
14Back PainFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
15Weight decreasedFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Chest PainFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
17OligohydramniosFAERS: 17OFFSIDES
US FAERS
18AstheniaFAERS: 16
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
19Feeling abnormalFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
20ArthralgiaFAERS: 15US FAERS
21Myocardial InfarctionFAERS: 15US FAERS
22PruritusFAERS: 15
Canada Vigilance: 7
Canada Vigilance
US FAERS
23Blood pressure fluctuationFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
24Memory impairmentFAERS: 14US FAERS
25MyalgiaFAERS: 14
Canada Vigilance: 5
Canada Vigilance
US FAERS
26AngioedemaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
27PainFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
28Intentional drug misuseFAERS: 12US FAERS
29StressFAERS: 12US FAERS
30Abdominal PainFAERS: 11
Canada Vigilance: 4
Canada Vigilance
US FAERS
31AnxietyFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
32PneumoniaFAERS: 11US FAERS
33AlopeciaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
34AmnesiaFAERS: 10US FAERS
35Blood creatinine increasedFAERS: 10
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
36Joint swellingFAERS: 10US FAERS
37NasopharyngitisFAERS: 10US FAERS
38SyncopeFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
39Visual ImpairmentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
40BradycardiaFAERS: 9OFFSIDES
US FAERS
41DyspepsiaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
42InfarctionFAERS: 9US FAERS
43PalpitationsFAERS: 9
Canada Vigilance: 10
Canada Vigilance
US FAERS
44VomitingFAERS: 9
Canada Vigilance: 12
Canada Vigilance
US FAERS
45Wrong technique in drug usage processFAERS: 9US FAERS
46AsthmaFAERS: 8OFFSIDES
US FAERS
47Cardiac ArrestFAERS: 8US FAERS
48Chest discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
49GoutFAERS: 8US FAERS
50Joint injuryFAERS: 8US FAERS
51Maternal exposure during pregnancyFAERS: 8US FAERS
52NervousnessFAERS: 8US FAERS
53SinusitisFAERS: 8OFFSIDES
US FAERS
54Suicide attemptFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
55ArthritisFAERS: 7US FAERS
56CholestasisFAERS: 7US FAERS
57Incorrect dose administeredFAERS: 7US FAERS
58VertigoFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
59Blood cholesterol increasedFAERS: 6US FAERS
60Erectile dysfunctionFAERS: 6US FAERS
61GlaucomaFAERS: 6US FAERS
62OverdoseFAERS: 6US FAERS
63Therapeutic response unexpectedFAERS: 6US FAERS
64Abdominal discomfortFAERS: 5
Canada Vigilance: 5
Canada Vigilance
US FAERS
65Acute kidney injuryFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
66AgitationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
67AphagiaFAERS: 5US FAERS
68Blood creatine phosphokinase increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
69CataractFAERS: 5OFFSIDES
US FAERS
70ConstipationFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
71Cytolytic hepatitisFAERS: 5OFFSIDES
US FAERS
72ErythemaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
73HepatitisFAERS: 5OFFSIDES
US FAERS
74Hypertensive crisisFAERS: 5US FAERS
75InfluenzaFAERS: 5US FAERS
76Medication ErrorFAERS: 5US FAERS
77Oropharyngeal painFAERS: 5US FAERS
78PancreatitisFAERS: 5US FAERS
79PregnancyFAERS: 5US FAERS
80Respiratory FailureFAERS: 5OFFSIDES
US FAERS
81SomnolenceFAERS: 5US FAERS
82TinnitusFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Urinary tract infectionFAERS: 5US FAERS
84Anal FissureFAERS: 4US FAERS
85AphasiaFAERS: 4US FAERS
86Blood cholesterol abnormalFAERS: 4US FAERS
87CardiomegalyFAERS: 410779124
11518847
CTD
US FAERS
88Cerebral InfarctionFAERS: 4US FAERS
89ChillsFAERS: 4US FAERS
90DisabilityFAERS: 4US FAERS
91Drug prescribing errorFAERS: 4US FAERS
92DysarthriaFAERS: 4US FAERS
93DysgeusiaFAERS: 4US FAERS
94DysphoniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
95DysuriaFAERS: 4US FAERS
96FlatulenceFAERS: 4US FAERS
97General physical health deteriorationFAERS: 4OFFSIDES
US FAERS
98HepatomegalyFAERS: 4US FAERS
99HypomaniaFAERS: 4OFFSIDES
US FAERS
100Intentional product misuseFAERS: 4US FAERS
101LethargyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Limb injuryFAERS: 4US FAERS
103LymphadenopathyFAERS: 4US FAERS
104MicrocephalyFAERS: 4US FAERS
105Musculoskeletal PainFAERS: 4US FAERS
106NeutropeniaFAERS: 4US FAERS
107PresyncopeFAERS: 4US FAERS
108Renal tubular disorderFAERS: 4OFFSIDES
US FAERS
109RhabdomyolysisFAERS: 4OFFSIDES
US FAERS
110SwellingFAERS: 4US FAERS
111ThrombosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
112WheezingFAERS: 4US FAERS
113AbasiaFAERS: 3US FAERS
114Alanine Aminotransferase IncreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
115Angina PectorisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
116AnosmiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
117AnuriaFAERS: 3US FAERS
118Blood urea increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
119BronchitisFAERS: 3US FAERS
120CellulitisFAERS: 3US FAERS
121ColitisFAERS: 3US FAERS
122Congenital cystic kidney diseaseFAERS: 3US FAERS
123DeafnessFAERS: 3US FAERS
124DiscomfortFAERS: 3US FAERS
125Expired drug administeredFAERS: 3US FAERS
126Familial TremorFAERS: 3US FAERS
127FlushingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
128Grip strength decreasedFAERS: 3US FAERS
129Hepatitis E antibody positiveFAERS: 3US FAERS
130HypersensitivityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
131Implantable defibrillator insertionFAERS: 3US FAERS
132Intestinal ObstructionFAERS: 3US FAERS
133Lip swellingFAERS: 3US FAERS
134Musculoskeletal stiffnessFAERS: 3US FAERS
135MyopathyFAERS: 3US FAERS
136Neck PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Renal cystFAERS: 3US FAERS
138RosaceaFAERS: 3US FAERS
139Sick Sinus SyndromeFAERS: 3OFFSIDES
US FAERS
140Skeletal injuryFAERS: 3US FAERS
141TachycardiaFAERS: 311518847CTD
US FAERS
142Throat irritationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
143TremorFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
144White blood cell count decreasedFAERS: 3US FAERS
145Accidental drug intake by childFAERS: 2US FAERS
146Accidental overdoseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Activities of daily living impairedFAERS: 2OFFSIDES
US FAERS
148Acute myocardial infarctionFAERS: 2OFFSIDES
US FAERS
149Acute prerenal failureFAERS: 2US FAERS
150Alpha 2 globulin increasedFAERS: 2US FAERS
151AneurysmFAERS: 2US FAERS
152AnhedoniaFAERS: 2OFFSIDES
US FAERS
153AnorexiaFAERS: 2OFFSIDES
US FAERS
154AphoniaFAERS: 2US FAERS
155ArteriosclerosisFAERS: 2OFFSIDES
US FAERS
156ArthropathyFAERS: 2US FAERS
157AscitesFAERS: 2OFFSIDES
US FAERS
158Aspartate Aminotransferase IncreasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
159Atrial FibrillationFAERS: 2US FAERS
160AuraFAERS: 2US FAERS
161BedriddenFAERS: 2US FAERS
162Biliary DyskinesiaFAERS: 2US FAERS
163Blood glucose decreasedFAERS: 2OFFSIDES
US FAERS
164Blood glucose increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Blood pressure immeasurableFAERS: 2US FAERS
166BronchopneumoniaFAERS: 2US FAERS
167Burning sensationFAERS: 2US FAERS
168CholangiolitisFAERS: 2OFFSIDES
US FAERS
169ChromaturiaFAERS: 2US FAERS
170Completed SuicideFAERS: 2US FAERS
171Counterfeit drug administeredFAERS: 2US FAERS
172CryingFAERS: 2US FAERS
173Depressed moodFAERS: 2US FAERS
174Diabetic NephropathyFAERS: 2US FAERS
175EcchymosisFAERS: 2US FAERS
176EczemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
177EmpyemaFAERS: 2US FAERS
178EosinophiliaFAERS: 2US FAERS
179Epstein-Barr virus antibody positiveFAERS: 2US FAERS
180Feeling of body temperature changeFAERS: 2US FAERS
181FibromyalgiaFAERS: 2US FAERS
182FormicationFAERS: 2US FAERS
183GastritisFAERS: 2US FAERS
184HemiplegiaFAERS: 2US FAERS
185Hepatitis CFAERS: 2US FAERS
186HerniaFAERS: 2OFFSIDES
US FAERS
187HydronephrosisFAERS: 2US FAERS
188Impaired work abilityFAERS: 2US FAERS
189Livedo ReticularisFAERS: 2US FAERS
190LymphopeniaFAERS: 2US FAERS
191Macular degenerationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
192MalabsorptionFAERS: 2US FAERS
193MeningorrhagiaFAERS: 2US FAERS
194MicroalbuminuriaFAERS: 2US FAERS
195Multiple drug overdoseFAERS: 2US FAERS
196NephritisFAERS: 2US FAERS
197OliguriaFAERS: 2US FAERS
198Ovarian Hyperstimulation SyndromeFAERS: 2OFFSIDES
US FAERS
199ParesisFAERS: 2US FAERS
200Patent ductus arteriosusFAERS: 2US FAERS
201PemphigusFAERS: 2US FAERS
202Peripheral artery thrombosisFAERS: 2US FAERS
203Peripheral swellingFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
204Peritoneal DialysisFAERS: 2US FAERS
205Product substitution issueFAERS: 2
Canada Vigilance: 73
Canada Vigilance
US FAERS
206Pulmonary Valve StenosisFAERS: 2US FAERS
207Rash erythematousFAERS: 2US FAERS
208Rectal dischargeFAERS: 2US FAERS
209Renal Artery StenosisFAERS: 2US FAERS
210Renal dysplasiaFAERS: 2US FAERS
211Respiratory distressFAERS: 2US FAERS
212Secretion dischargeFAERS: 2US FAERS
213Septic ShockFAERS: 2US FAERS
214Sexual DysfunctionFAERS: 2US FAERS
215ShockFAERS: 2US FAERS
216Skin reactionFAERS: 2US FAERS
217SomnambulismFAERS: 2US FAERS
218StillbirthFAERS: 2US FAERS
219Therapy cessationFAERS: 2US FAERS
220ThrombocytopeniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
221UlcerFAERS: 2US FAERS
222Urinary IncontinenceFAERS: 2US FAERS
223Urinary RetentionFAERS: 2US FAERS
224VasculitisFAERS: 2US FAERS
225Venous occlusionFAERS: 2US FAERS
226Wound InfectionFAERS: 2US FAERS
227Wrong drug administeredFAERS: 2US FAERS
228AgeusiaFAERS: 1US FAERS
229Allergy to chemicalsFAERS: 1US FAERS
230AngiosclerosisFAERS: 1US FAERS
231Angiotensin converting enzyme inhibitor foetopathyFAERS: 1US FAERS
232Aortic AneurysmFAERS: 1US FAERS
233Arteritis obliteransFAERS: 1US FAERS
234Atrioventricular BlockFAERS: 1OFFSIDES
US FAERS
235Autoimmune thrombocytopeniaFAERS: 1US FAERS
236Autonomic nervous system imbalanceFAERS: 1US FAERS
237Basal cell carcinomaFAERS: 1US FAERS
238Basal ganglia strokeFAERS: 1US FAERS
239Bile Duct StenosisFAERS: 1US FAERS
240Bipolar DisorderFAERS: 1US FAERS
241BlindnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Blood GlucoseFAERS: 1US FAERS
243Blood amylase increasedFAERS: 1US FAERS
244Blood creatine abnormalFAERS: 1US FAERS
245Blood creatine increasedFAERS: 1US FAERS
246Blood creatine phosphokinase MBFAERS: 1US FAERS
247Blood glucose abnormalFAERS: 1US FAERS
248Blood immunoglobulin G increasedFAERS: 1US FAERS
249Blood potassium decreasedFAERS: 1OFFSIDES
US FAERS
250Blood potassium increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
251Blood sodium decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Blood triglycerides abnormalFAERS: 1US FAERS
253Blood triglycerides increasedFAERS: 1OFFSIDES
US FAERS
254Blood urea abnormalFAERS: 1US FAERS
255Bone density decreasedFAERS: 1US FAERS
256Bone painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
257Breast cancer recurrentFAERS: 1US FAERS
258Breast discomfortFAERS: 1US FAERS
259BronchospasmFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
260BursitisFAERS: 1OFFSIDES
US FAERS
261CalcinosisFAERS: 1US FAERS
262Cardiac FlutterFAERS: 1US FAERS
263Carpal Tunnel SyndromeFAERS: 1US FAERS
264Cell DeathFAERS: 1US FAERS
265Cerebral calcificationFAERS: 1US FAERS
266ChemotherapyFAERS: 1US FAERS
267Choking sensationFAERS: 1US FAERS
268Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
269Congenital renal disorderFAERS: 1US FAERS
270Coronary Artery DiseaseFAERS: 1US FAERS
271Croup infectiousFAERS: 1US FAERS
272CystitisFAERS: 1US FAERS
273CystFAERS: 1OFFSIDES
US FAERS
274DehydrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
275DeliriumFAERS: 1US FAERS
276DementiaFAERS: 1US FAERS
277Dengue FeverFAERS: 1US FAERS
278Dental cariesFAERS: 1US FAERS
279Depression suicidalFAERS: 1US FAERS
280Device breakageFAERS: 1US FAERS
281Diabetes mellitus inadequate controlFAERS: 1US FAERS
282DiplopiaFAERS: 1US FAERS
283Disease recurrenceFAERS: 1US FAERS
284DisorientationFAERS: 1US FAERS
285Drug administration errorFAERS: 1US FAERS
286Drug dispensing errorFAERS: 1US FAERS
287DuodenitisFAERS: 1US FAERS
288DysplasiaFAERS: 1US FAERS
289Ear discomfortFAERS: 1US FAERS
290Ejection Fraction DecreasedFAERS: 1OFFSIDES
US FAERS
291EpilepsyFAERS: 1US FAERS
292EpistaxisFAERS: 1OFFSIDES
US FAERS
293Epstein-Barr virus antigen positiveFAERS: 1US FAERS
294EructationFAERS: 1US FAERS
295Essential TremorFAERS: 1US FAERS
296Extremity contractureFAERS: 1US FAERS
297Eye painFAERS: 1US FAERS
298Eyelid painFAERS: 1US FAERS
299Facial ParesisFAERS: 1US FAERS
300Facial asymmetryFAERS: 1US FAERS
301Failure to ThriveFAERS: 1US FAERS
302Feeling jitteryFAERS: 1US FAERS
303Frustration tolerance decreasedFAERS: 1US FAERS
304Gamma-Glutamyltransferase IncreasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
305Gastrointestinal PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
306Gastrointestinal tract adenomaFAERS: 1US FAERS
307Gastrointestinal viral infectionFAERS: 1US FAERS
308Gingival HyperplasiaFAERS: 1US FAERS
309GlycosuriaFAERS: 1US FAERS
310Granuloma AnnulareFAERS: 1US FAERS
311Head circumference abnormalFAERS: 1US FAERS
312Head discomfortFAERS: 1US FAERS
313Helicobacter pylori identification test positiveFAERS: 1US FAERS
314Hepatic necrosisFAERS: 1US FAERS
315Hepatitis B antibody positiveFAERS: 1US FAERS
316Hepatitis B positiveFAERS: 1US FAERS
317Hepatitis EFAERS: 1US FAERS
318HepatosplenomegalyFAERS: 1US FAERS
319Hernia obstructiveFAERS: 1US FAERS
320HungerFAERS: 1US FAERS
321HypertrichosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
322HypospadiasFAERS: 1US FAERS
323Immature respiratory systemFAERS: 1US FAERS
324Implant site reactionFAERS: 1US FAERS
325Inappropriate schedule of drug administrationFAERS: 1US FAERS
326Incorrect storage of drugFAERS: 1US FAERS
327Increased bronchial secretionFAERS: 1US FAERS
328Increased tendency to bruiseFAERS: 1US FAERS
329InfectionFAERS: 1US FAERS
330Insulin autoimmune syndromeFAERS: 1US FAERS
331Intentional misuseFAERS: 1US FAERS
332Intentional self-injuryFAERS: 1US FAERS
333Intervertebral Disc DegenerationFAERS: 1US FAERS
334Intracranial AneurysmFAERS: 1OFFSIDES
US FAERS
335Labile blood pressureFAERS: 1US FAERS
336LaryngitisFAERS: 1US FAERS
337Left Ventricular HypertrophyFAERS: 1US FAERS
338LeukopeniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
339Libido disorderFAERS: 1US FAERS
340Limb discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
341Limb operationFAERS: 1US FAERS
342Limb salvage therapyFAERS: 1US FAERS
343Loose toothFAERS: 1US FAERS
344Low birth weight babyFAERS: 1US FAERS
345Low set earsFAERS: 1US FAERS
346Lupus NephritisFAERS: 1US FAERS
347LymphomaFAERS: 1US FAERS
348MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
349MacroglossiaFAERS: 1OFFSIDES
US FAERS
350Male sexual dysfunctionFAERS: 1US FAERS
351Medical device complicationFAERS: 1US FAERS
352Medication residueFAERS: 1US FAERS
353Mental retardation severity unspecifiedFAERS: 1US FAERS
354Mental status changesFAERS: 1US FAERS
355MetastasisFAERS: 1US FAERS
356Muscle tightnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
357Musculoskeletal chest painFAERS: 1US FAERS
358Musculoskeletal discomfortFAERS: 1US FAERS
359MyocarditisFAERS: 1US FAERS
360Nasal inflammationFAERS: 1US FAERS
361Neonatal disorderFAERS: 1US FAERS
362Neonatal hypotensionFAERS: 1US FAERS
363NephrectomyFAERS: 1US FAERS
364NephrocalcinosisFAERS: 1US FAERS
365NephrolithiasisFAERS: 1US FAERS
366Nerve injuryFAERS: 1US FAERS
367Night sweatsFAERS: 1US FAERS
368No adverse effectFAERS: 1US FAERS
369No adverse eventFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
370ObesityFAERS: 1US FAERS
371Oculomucocutaneous syndromeFAERS: 1US FAERS
372OphthalmoplegiaFAERS: 1US FAERS
373Oral painFAERS: 1US FAERS
374Osteogenesis ImperfectaFAERS: 1US FAERS
375OsteoporosisFAERS: 1OFFSIDES
US FAERS
376Otitis MediaFAERS: 1US FAERS
377OtosclerosisFAERS: 1US FAERS
378OverweightFAERS: 1US FAERS
379Pancreatic NeoplasmFAERS: 1US FAERS
380PancytopeniaFAERS: 1US FAERS
381Papillary muscle infarctionFAERS: 1US FAERS
382Parotid gland inflammationFAERS: 1US FAERS
383Penile curvatureFAERS: 1US FAERS
384PeriarthritisFAERS: 1US FAERS
385Pericardial effusionFAERS: 1US FAERS
386PeriodontitisFAERS: 1US FAERS
387Pharmaceutical product complaintFAERS: 1US FAERS
388Pharyngolaryngeal PainFAERS: 1US FAERS
389PhotodermatosisFAERS: 1US FAERS
390PolychondritisFAERS: 1US FAERS
391Poor quality sleepFAERS: 1US FAERS
392Poor sucking reflexFAERS: 1US FAERS
393Product dispensing errorFAERS: 1US FAERS
394Product use issueFAERS: 1US FAERS
395ProstatectomyFAERS: 1US FAERS
396ProteinuriaFAERS: 115561744
16802178
18175062
CTD
US FAERS
397PsoriasisFAERS: 1US FAERS
398Pulmonary FibrosisFAERS: 1US FAERS
399Pulmonary arterial hypertensionFAERS: 1US FAERS
400Pulmonary function test decreasedFAERS: 1US FAERS
401RegurgitationFAERS: 1US FAERS
402Renal Cell CarcinomaFAERS: 1US FAERS
403Renal aneurysmFAERS: 1US FAERS
404Renal failure neonatalFAERS: 1US FAERS
405Renal hypertensionFAERS: 1US FAERS
406Renal painFAERS: 1US FAERS
407Renal vessel congenital anomalyFAERS: 1US FAERS
408Restless Legs SyndromeFAERS: 1US FAERS
409RetchingFAERS: 1US FAERS
410Rotator cuff syndromeFAERS: 1US FAERS
411SciaticaFAERS: 1US FAERS
412Skin irritationFAERS: 1US FAERS
413Skin lesionFAERS: 1US FAERS
414Sleep disorder due to a general medical conditionFAERS: 1US FAERS
415SneezingFAERS: 1US FAERS
416Spinal column injuryFAERS: 1US FAERS
417Sprue-like enteropathyFAERS: 1US FAERS
418SteatohepatitisFAERS: 1US FAERS
419Stevens-Johnson SyndromeFAERS: 1US FAERS
420StomatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
421Stress at workFAERS: 1US FAERS
422Temporal ArteritisFAERS: 1US FAERS
423Tension HeadacheFAERS: 1OFFSIDES
US FAERS
424TensionFAERS: 1US FAERS
425Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
426Throat cancerFAERS: 1US FAERS
427Tooth LossFAERS: 1US FAERS
428ToothacheFAERS: 1US FAERS
429Toxicity to various agentsFAERS: 1US FAERS
430Transaminases increasedFAERS: 1OFFSIDES
US FAERS
431Transcription medication errorFAERS: 1US FAERS
432TrichorrhexisFAERS: 1US FAERS
433Unequal Limb LengthFAERS: 1US FAERS
434Upper respiratory tract congestionFAERS: 1US FAERS
435Urinary Tract PainFAERS: 1US FAERS
436Urine output increasedFAERS: 1US FAERS
437UrticariaFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
438VIIth nerve paralysisFAERS: 1US FAERS
439Vasculitic rashFAERS: 1US FAERS
440Venous ThrombosisFAERS: 1US FAERS
441Violence-related symptomFAERS: 1US FAERS
442Vitamin D DeficiencyFAERS: 1US FAERS
443Vocal Cord ParalysisFAERS: 1US FAERS
444Wrong technique in product usage processFAERS: 1US FAERS
445colonoscopyFAERS: 1US FAERS
446jaundiceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
447muscle injuryFAERS: 1US FAERS
448pH urine decreasedFAERS: 1US FAERS
449Abdominal AbscessOFFSIDES
450AbuseOFFSIDES
451AcidosisOFFSIDES
452ActinomycosisOFFSIDES
453AgranulocytosisCanada Vigilance: 1Canada Vigilance
454Airway burnsCanada Vigilance: 1Canada Vigilance
455Alcohol poisoningOFFSIDES
456Amylase abnormalCanada Vigilance: 1Canada Vigilance
457ApathyOFFSIDES
458Application site urticariaOFFSIDES
459Arteriovenous graft site infectionOFFSIDES
460AtherosclerosisOFFSIDES
461Atrial tachycardiaOFFSIDES
462Back disorderOFFSIDES
463BereavementOFFSIDES
464Bile duct cancer stage IIIOFFSIDES
465BlepharitisOFFSIDES
466Blood alkaline phosphatase increasedCanada Vigilance: 2Canada Vigilance
OFFSIDES
467Blood bilirubin abnormalCanada Vigilance: 1Canada Vigilance
468Blood chloride decreasedOFFSIDES
469Blood immunoglobulin A increasedOFFSIDES
470Blood lactate dehydrogenase abnormalCanada Vigilance: 1Canada Vigilance
471Blood lactate dehydrogenase increasedOFFSIDES
472Blood potassium abnormalCanada Vigilance: 1Canada Vigilance
473Blood sodium abnormalCanada Vigilance: 1Canada Vigilance
474Blood sodiumOFFSIDES
475Blood thyroid stimulating hormone increasedOFFSIDES
476Blood urine presentOFFSIDES
477Bone marrow depressionOFFSIDES
478Bowel movement irregularityOFFSIDES
479Buccal mucosal rougheningOFFSIDES
480Cardioactive drug levelOFFSIDES
481Cardiomyopathy, Dilated22120037CTD
482Cerebral ArteriosclerosisOFFSIDES
483Cerebral atrophyOFFSIDES
484Charles Bonnet SyndromeOFFSIDES
485Chemotherapeutic drug level increasedOFFSIDES
486Cholecystitis infectiveOFFSIDES
487Clostridium colitisOFFSIDES
488Cold sweatOFFSIDES
489ColectomyOFFSIDES
490ConfabulationOFFSIDES
491Congenital tricuspid valve incompetenceOFFSIDES
492Conjunctival depositOFFSIDES
493CystoceleOFFSIDES
494Cytomegalovirus test positiveOFFSIDES
495Deafness NeurosensoryOFFSIDES
496Decreased LibidoOFFSIDES
497Dental FistulaOFFSIDES
498Dental cleaningOFFSIDES
499DermatitisCanada Vigilance: 1Canada Vigilance
500DiarrheaOFFSIDES
501DrowsinessOFFSIDES
502Drug ineffective for unapproved indicationCanada Vigilance: 8Canada Vigilance
503Dry skinCanada Vigilance: 2Canada Vigilance
504Dyspnoea exacerbatedOFFSIDES
505Electrocardiogram ST segment abnormalOFFSIDES
506Electromechanical dissociationOFFSIDES
507Endodontic procedureOFFSIDES
508Enterobacter pneumoniaOFFSIDES
509Erosive gastritisOFFSIDES
510ErysipelasOFFSIDES
511Facial NeuralgiaOFFSIDES
512Fistula repairOFFSIDES
513Fluid overloadOFFSIDES
514Foreign body traumaOFFSIDES
515Gastric ulcerOFFSIDES
516GastroenteritisOFFSIDES
517Gene MutationCanada Vigilance: 1Canada Vigilance
518GlobulinuriaOFFSIDES
519Glomerulonephritis15561744CTD
520Heart Diseases16923758CTD
521Heart failure14737854
15167280
15548724
CTD
522HemiparesisOFFSIDES
523IncontinenceOFFSIDES
524Increased viscosity of bronchial secretionCanada Vigilance: 1Canada Vigilance
525Infusion site inflammationOFFSIDES
526Injection site infectionOFFSIDES
527Intestinal PerforationOFFSIDES
528Iodine uptake increasedOFFSIDES
529IridocyclitisOFFSIDES
530Joint stiffnessOFFSIDES
531Kidney Diseases16923758CTD
532Kidney FailureOFFSIDES
533Large intestine perforationOFFSIDES
534LeukoencephalopathyOFFSIDES
535Ligament injuryOFFSIDES
536Liver Cirrhosis, Experimental14620537CTD
537Lyme DiseaseOFFSIDES
538Mastication disorderOFFSIDES
539Mechanical ventilationOFFSIDES
540MetatarsalgiaOFFSIDES
541Muscle strainOFFSIDES
542Nephritis allergicOFFSIDES
543Nephrogenic Fibrosing DermopathyOFFSIDES
544Neurological examination abnormalOFFSIDES
545Neutropenic sepsisOFFSIDES
546Occult blood positiveOFFSIDES
547Oral infectionOFFSIDES
548OsteopeniaOFFSIDES
549PROTHROMBIN TIMEOFFSIDES
550Pain of skinOFFSIDES
551ParanoiaCanada Vigilance: 1Canada Vigilance
552Pelvic prolapseOFFSIDES
553Peripheral embolismOFFSIDES
554Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
555Physical disabilityOFFSIDES
556Polymyalgia RheumaticaOFFSIDES
557PolyneuropathyOFFSIDES
558Polysubstance abuseOFFSIDES
559Postoperative abscessOFFSIDES
560Potentiating drug interactionOFFSIDES
561Product lot number issueCanada Vigilance: 1Canada Vigilance
562Product quality issueCanada Vigilance: 2Canada Vigilance
563Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
564Protein total decreasedOFFSIDES
565Pulmonary HypertensionOFFSIDES
566PurulenceOFFSIDES
567PyelonephritisOFFSIDES
568Radicular painOFFSIDES
569RalesOFFSIDES
570RectoceleOFFSIDES
571Renal tubular atrophyOFFSIDES
572Renal tubular necrosisOFFSIDES
573Restrictive pulmonary diseaseOFFSIDES
574RhabdomyosarcomaOFFSIDES
575Rotavirus test positiveOFFSIDES
576SequestrectomyOFFSIDES
577Shoulder PainOFFSIDES
578SinobronchitisOFFSIDES
579Sinus operationOFFSIDES
580Skin hypertrophyOFFSIDES
581Spinal column stenosisOFFSIDES
582StridorOFFSIDES
583Sudden Cardiac DeathOFFSIDES
584Supraventricular tachycardiaCanada Vigilance: 1Canada Vigilance
585Synovial CystOFFSIDES
586TetanyOFFSIDES
587Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
588Therapeutic response changedCanada Vigilance: 1Canada Vigilance
589ThrombophlebitisOFFSIDES
590Tongue bitingOFFSIDES
591Transferrin decreasedOFFSIDES
592Ultrasound abdomen abnormalOFFSIDES
593Unresponsive to verbal stimuliOFFSIDES
594Vascular Remodeling25464244
27889505
CTD
595Vena cava filter insertionOFFSIDES
596Ventricular FibrillationOFFSIDES
597Ventricular Remodeling27085127CTD
598White blood cell count abnormalCanada Vigilance: 1Canada Vigilance
599fibromaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.